Open access · OA
via Europe PMC
Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening
Authors not listed
Innovation in aging · 2025
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2025). Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12761944
Vancouver
Anonymous. Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening. Innovation in aging. 2025.
BibTeX
@article{anon2025Target,
title = {Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2019
Open access · CC-BY
mTOR and Aging: An Old Fashioned Dress
Nature reviews. Cancer 2002
Open access · OA
Papillomaviruses and cancer: from basic studies to clinical application
Nature Clinical Practice Cardiovascular Medicine 2008
Citation only
Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025
Open access · OA
Microvascular Health as a Key Determinant of Organismal Aging.
Cell 2023
Open access · OA
Resurrection of endogenous retroviruses during aging reinforces senescence
Clinical and Translational Discovery 2024
Open access · CC-BY